Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion

Mizuki TagamiOphthalmology Department, Eye Center, Kobe Kaisei Hospital, Kobe, Hyogo, JapanCorrespondence[email protected]

Ryuto SaiOphthalmology Department, Eye Center, Kobe Kaisei Hospital, Kobe, Hyogo, Japan

Masahide FukudaOphthalmology Department, Eye Center, Kobe Kaisei Hospital, Kobe, Hyogo, Japan

Atsushi AzumiOphthalmology Department, Eye Center, Kobe Kaisei Hospital, Kobe, Hyogo, Japan

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (7)

HD Jeffry Hogg, Sandro Di Simplicio & Mark S Pearce. (2020) Ranibizumab and aflibercept intravitreal injection for treatment naïve and refractory macular oedema in branch retinal vein occlusion. European Journal of Ophthalmology 31:2, pages 548-555.
Crossref

Kimberly Spooner, Samantha Fraser-Bell, Thomas Hong & Andrew Chang. (2021) Patient-reported outcomes from a phase IV study of aflibercept in patients with refractory retinal vein occlusions. Taiwan Journal of Ophthalmology 11:3, pages 244.
Crossref

Omar Moinuddin, Sanjana Sathrasala, K. Thiran Jayasundera, Kari H. Branham, Emmanuel Y. Chang, Cynthia X. Qian, Franco M. Recchia, Abigail T. Fahim & Cagri G. Besirli. (2021) Coats-like Exudative Vitreoretinopathy in Retinitis Pigmentosa. Ophthalmology Retina 5:1, pages 86-96.
Crossref

Manuel AP Vilela. (2020) Use of Anti-VEGF Drugs in Retinal Vein Occlusions. Current Drug Targets 21:12, pages 1181-1193.
Crossref

Kimberly Spooner, Samantha Fraser‐Bell, Thomas Hong & Andrew Chang. (2019) Prospective study of aflibercept for the treatment of persistent macular oedema secondary to retinal vein occlusions in eyes not responsive to long‐term treatment with bevacizumab or ranibizumab. Clinical & Experimental Ophthalmology 48:1, pages 53-60.
Crossref

Kimberly Spooner, Thomas Hong, Bobak Bahrami & Andrew Chang. (2019) A meta-analysis of patients with treatment-resistant macular oedema secondary to retinal vein occlusions following switching to aflibercept. Acta Ophthalmologica 97:1, pages 15-23.
Crossref

Vasileios E. Konidaris, Konstantinos T. Tsaousis, Rossella Anzidei, Guillermo de la Mata & Alexander J. Brent. (2018) Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion. Ophthalmology and Therapy 7:2, pages 387-395.
Crossref

Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion

Articles from other publishers (7)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion

Citations (7)

Articles from other publishers (7)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date